Results from a mathematical model for human monocytic ehrlichiosis

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
Benchmarking inappropriate empirical antibiotic treatment
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Climate and genotypes of Pneumocystis jirovecii
Vector control: a cornerstone in the malaria elimination campaign
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?
Training for the infectious diseases speciality in Norway
Methods to assess seasonal effects in epidemiological studies of infectious diseases— exemplified by application to the occurrence of meningococcal disease 
Laboratory diagnosis and biosafety issues of biological warfare agents
CMI editorial report 2011 Clinical Microbiology and Infection
C. Fabrizio, A. Procopio  Clinical Microbiology and Infection 
Elements of design: the knowledge on which we build
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
U. Sagel, R.T. Mikolajczyk, A. Krämer 
Laboratory diagnosis of Clostridium difficile disease
Rickettsia felis and Rickettsia massiliae in Ivory Coast, Africa
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
The role of antimalarial treatment in the elimination of malaria
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Benchmarking inappropriate empirical antibiotic treatment
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Vaccines for the elderly
C. Wongsrichanalai, C.H. Sibley  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
D. Baud, C. Kebbi, J.-P. Külling, G. Greub 
O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger 
S. Shpynov, N. Rudakov, Y. Tohkov, A. Matushchenko, I. Tarasevich, D
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
C. Socolovschi, D. Raoult, P. Parola 
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Results from a mathematical model for human monocytic ehrlichiosis H. Gaff, L. Gross, E. Schaefer  Clinical Microbiology and Infection  Volume 15, Pages 15-16 (December 2009) DOI: 10.1111/j.1469-0691.2008.02131.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Average percentage of infected ticks in the endemic (solid blue) and disease-free (dotted red) patches after 1000 months. Migration rates must be very low in order for the individual patches to retain their natural disease dynamics. Clinical Microbiology and Infection 2009 15, 15-16DOI: (10.1111/j.1469-0691.2008.02131.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.